297 related articles for article (PubMed ID: 29702409)
1. Clinical outcomes of VNS therapy with AspireSR
Hamilton P; Soryal I; Dhahri P; Wimalachandra W; Leat A; Hughes D; Toghill N; Hodson J; Sawlani V; Hayton T; Samarasekera S; Bagary M; McCorry D; Chelvarajah R
Seizure; 2018 May; 58():120-126. PubMed ID: 29702409
[TBL] [Abstract][Full Text] [Related]
2. Additional seizure reduction by replacement with Vagus Nerve Stimulation Model 106 (AspireSR).
Kawaji H; Yamamoto T; Fujimoto A; Uchida D; Ichikawa N; Yamazoe T; Okanishi T; Sato K; Nishimura M; Tanaka T; Namba H
Neurosci Lett; 2020 Jan; 716():134636. PubMed ID: 31751671
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy.
Tzadok M; Harush A; Nissenkorn A; Zauberman Y; Feldman Z; Ben-Zeev B
Seizure; 2019 Oct; 71():140-144. PubMed ID: 31326720
[TBL] [Abstract][Full Text] [Related]
4. Seizure improvement following vagus nerve stimulator (VNS) battery change with cardiac-based seizure detection automatic stimulation (AutoStim): early experience in a regional paediatric unit.
Lo WB; Chevill B; Philip S; Agrawal S; Walsh AR
Childs Nerv Syst; 2021 Apr; 37(4):1237-1241. PubMed ID: 33174154
[TBL] [Abstract][Full Text] [Related]
5. Vagus nerve stimulation with tachycardia detection provides additional seizure reduction compared to traditional vagus nerve stimulation.
Datta P; Galla KM; Sajja K; Wichman C; Wang H; Madhavan D
Epilepsy Behav; 2020 Oct; 111():107280. PubMed ID: 32759064
[TBL] [Abstract][Full Text] [Related]
6. Implantation of a new Vagus Nerve Stimulation (VNS) Therapy® generator, AspireSR®: considerations and recommendations during implantation and replacement surgery--comparison to a traditional system.
Schneider UC; Bohlmann K; Vajkoczy P; Straub HB
Acta Neurochir (Wien); 2015 Apr; 157(4):721-8. PubMed ID: 25673257
[TBL] [Abstract][Full Text] [Related]
7. A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation.
Boon P; Vonck K; van Rijckevorsel K; El Tahry R; Elger CE; Mullatti N; Schulze-Bonhage A; Wagner L; Diehl B; Hamer H; Reuber M; Kostov H; Legros B; Noachtar S; Weber YG; Coenen VA; Rooijakkers H; Schijns OE; Selway R; Van Roost D; Eggleston KS; Van Grunderbeek W; Jayewardene AK; McGuire RM
Seizure; 2015 Nov; 32():52-61. PubMed ID: 26552564
[TBL] [Abstract][Full Text] [Related]
8. Baseline elevation and reduction in cardiac electrical instability assessed by quantitative T-wave alternans in patients with drug-resistant epilepsy treated with vagus nerve stimulation in the AspireSR E-36 trial.
Verrier RL; Nearing BD; Olin B; Boon P; Schachter SC
Epilepsy Behav; 2016 Sep; 62():85-9. PubMed ID: 27450311
[TBL] [Abstract][Full Text] [Related]
9. Long-term Expectations of Vagus Nerve Stimulation: A Look at Battery Replacement and Revision Surgery.
Couch JD; Gilman AM; Doyle WK
Neurosurgery; 2016 Jan; 78(1):42-6. PubMed ID: 26678088
[TBL] [Abstract][Full Text] [Related]
10. Evaluating vagus nerve stimulation treatment with heart rate monitoring in pediatric patients with intractable epilepsy.
Santhumayor B; Karkare S; Kothare S; Rodgers S
Childs Nerv Syst; 2022 Mar; 38(3):547-556. PubMed ID: 34837500
[TBL] [Abstract][Full Text] [Related]
11. Investigating the correlation between short-term effectiveness of VNS Therapy in reducing the severity of seizures and long-term responsiveness.
Ravan M
Epilepsy Res; 2017 Jul; 133():46-53. PubMed ID: 28414968
[TBL] [Abstract][Full Text] [Related]
12. Single-center long-term results of vagus nerve stimulation for epilepsy: A 10-17 year follow-up study.
Chrastina J; Novák Z; Zeman T; Kočvarová J; Pail M; Doležalová I; Jarkovský J; Brázdil M
Seizure; 2018 Jul; 59():41-47. PubMed ID: 29738985
[TBL] [Abstract][Full Text] [Related]
13. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.
Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T
Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Automatic Stimulations in Responsive Vagal Nerve Stimulation in Patients With Refractory Epilepsy.
Kulju T; Haapasalo J; Verner R; Dibué-Adjei M; Lehtimäki K; Rainesalo S; Peltola J
Neuromodulation; 2020 Aug; 23(6):852-858. PubMed ID: 32840019
[TBL] [Abstract][Full Text] [Related]
15. Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance--The U.S. E-37 Trial.
Fisher RS; Afra P; Macken M; Minecan DN; Bagić A; Benbadis SR; Helmers SL; Sinha SR; Slater J; Treiman D; Begnaud J; Raman P; Najimipour B
Neuromodulation; 2016 Feb; 19(2):188-95. PubMed ID: 26663671
[TBL] [Abstract][Full Text] [Related]
16. Autostimulation in Vagus Nerve Stimulator Treatment: Modulating Neuromodulation.
Kulju T; Haapasalo J; Rainesalo S; Lehtimäki K; Peltola J
Neuromodulation; 2019 Jul; 22(5):630-637. PubMed ID: 30549376
[TBL] [Abstract][Full Text] [Related]
17. Vagus nerve stimulation for 6- to 12-year-old children with refractory epilepsy: Impact on seizure frequency and parenting stress index.
Fan HC; Hsu TR; Chang KP; Chen SJ; Tsai JD;
Epilepsy Behav; 2018 Jun; 83():119-123. PubMed ID: 29702412
[TBL] [Abstract][Full Text] [Related]
18. Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review.
Toffa DH; Touma L; El Meskine T; Bouthillier A; Nguyen DK
Seizure; 2020 Dec; 83():104-123. PubMed ID: 33120323
[TBL] [Abstract][Full Text] [Related]
19. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
20. Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.
Siddiqui F; Herial NA; Ali II
Epilepsy Behav; 2010 Jul; 18(3):299-302. PubMed ID: 20580901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
